N/A N=151 Study of Forceps Cannulation During ERCP
Post-ERCP Acute Pancreatitis
Primary: Cannulation Success Rate and Difficult Cannulation Rate — 70; 68; 0; 13 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=72 Preventing Seroma Formation After Stripping Saphenous Vein in Coronary Bypass
Coronary Bypass Graft Stenosis of Autologous Vein
Primary: Early Complications of Vascular Zone — 1; 4; 15; 5 participants — p=0.05
N/A N=10 Coronal Mode Ultrasound Guided Hemodialysis Cannulation: Comparison With Standard Cannulation Technique
Arteriovenous Fistula, Cannulation
Primary: Infiltration Due to Dialysis Access Cannulation — 5; 7 infiltration events
N/A N=50 Ultrasound-Guided Peripheral Venous Access Using AccuCath
Intravenous Access
Primary: First Attempt Success Rate — 17; 11 Participants
N/A N=749 Ultrasound-image Guided Versus Doppler Guided Versus Palpation Technique for Arterial Cannulation in Adults
Anesthesia
Primary: First Attempt Success Rate With 3 Different Technique — 132; 101; 96 participants
N/A N=102 Saphenous Vein Cannulation in Infants and Small Children
Saphenous Vein Cannulation
Primary: Percentage of Participants With First Attempt Success of Saphenous Vein Cannulation — 51.0; 90.2 percent of participants
Phase 3 N=173 Aggressive Cholesterol Therapy to Inhibit Vein Graft Events After CABG (ACTIVE Trial)
Saphenous Vein Graft Disease
Primary: Saphenous Vein Graft Occlusion (Percentage of Vein Grafts Occluded) Based on CT Coronary Angiography at 1 Year — 14; 16 Vein grafts
N/A N=150 A Prospective Trial of Ultrasound Versus Landmark Guided Central Venous Access in the Pediatric Population
Need for Central Venous Access
Primary: Success of Central Venous Cannulation at First Attempt — 38; 43 Participants
N/A N=184 A Comparison of the First Attempt Success Rate of Cannulation Between the Accuvein Apparatus and Standard Technique
Procedural Complication
Primary: First Attempt Success Rates With the AccuVein 300 Device Versus Standard Method — 92; 92 Participants
N/A N=94 Saphenous Nerve Block Versus Femoral Nerve Block for Total Knee Arthroplasty
Total Knee Arthroplasty
Primary: Quadriceps Muscle Strength — 7.3; 2.2 kilogram-force
N/A N=32 Evaluation of Continuous Saphenous Nerve Block to Supplement a Continuous Sciatic Nerve Block After Ankle Surgery
Orthopedic Surgery of Lower Extremity
Primary: Verbal Pain Scores — 4.2; 5.4 units on a scale
N/A N=60 Saphenous Nerve Block vs. Femoral Nerve Block for Total Knee Arthroplasty
Difference Between Femoral Nerve Block and Saphenous Block
Primary: Visual Analogue Scale Pain Score — 2.81; 2.47 units on a scale
Phase 4 N=250 Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis
Saphenous Vein Graft Disease
Primary: Saphenous Vein Graft Occlusion — 17.4; 13.2 percentage of veins occluded
N/A N=100 Technique for Successful Ultrasound-guided Peripheral Vascular Access
Obesity · Vascular Diseases
Primary: Successful First Attempt Peripheral Venous Cannulation — 96 participants
Phase 4 N=597 Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty
Saphenous Vein Graft Atherosclerosis
Primary: Number of Participants With Target Vessel Failure (TVF), Defined as the Composite of Cardiac Death — 16; 17 Participants